Skip to main content
Beximco Pharmaceuticals Ltd. logo

Beximco Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · BXP ISIN · US0885792061 LEI · 213800IMBBD6TIOQGB56 IL Manufacturing
Open in API
Filings indexed 125 across all filing types
Latest filing 2021-01-14 Regulatory Filings
Country BD Bangladesh
Listing IL BXP

About Beximco Pharmaceuticals Ltd.

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd. is a manufacturer of generic drugs and active pharmaceutical ingredients (APIs). The company produces a broad portfolio of over 500 products across various therapeutic categories, with a focus on providing access to affordable medicines. It has established a strong market differentiation through a range of high-tech, specialized products, including metered-dose and dry powder inhalers. Serving numerous emerging and developed markets globally, its manufacturing facilities are accredited by major international regulatory authorities, including those of the USA, European Union, Australia, and Canada.

Recent filings

Filing Released Lang Actions
Update on the supply of COVID-19 vaccine
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Beximco Pharmaceuticals Ltd regarding the supply and distribution of a COVID-19 vaccine. It provides a business update on regulatory approvals, purchase agreements, and distribution plans. Since it is a general regulatory announcement regarding company operations and business updates that does not fit into specific categories like financial reports, M&A, or dividends, it falls under the RNS (Regulatory Filings) category.
2021-01-14 English
Stock Dividend Issued
Regulatory Filings Classification · 1% confidence The document is an RNS announcement from Beximco Pharmaceuticals Ltd regarding the issuance and admission of new shares (Global Depository Receipts) resulting from a previously approved stock dividend. Because the document specifically details the issuance of new shares and the resulting change in total issued share capital, it falls under the category of Share Issue/Capital Change.
2021-01-11 English
Confirmation of Board Changes
Board/Management Information Classification · 1% confidence The document is an official announcement from Beximco Pharmaceuticals Ltd regarding the confirmation of new Non-Executive Directors to the Board. It details the completion of due diligence and provides biographical information for the new directors as required by AIM Rules. This falls squarely under the category of board and management changes.
2021-01-11 English
AGM Statement
AGM Information Classification · 1% confidence The document is an official announcement from Beximco Pharmaceuticals Limited regarding the results of their Annual General Meeting (AGM). It explicitly states that all resolutions were passed, including the approval of cash and stock dividends. While it mentions the Annual Report, it is not the report itself, but rather a summary of the meeting outcomes and dividend declarations. Given the primary focus on the voting results of the AGM, it fits the DVA (Declaration of Voting Results) category.
2020-12-21 English
Board Changes
Board/Management Information Classification · 1% confidence The document is an official announcement from Beximco Pharmaceuticals Ltd regarding the appointment of two new Non-Executive Directors. It explicitly states 'Board Changes' in the header and provides details about the new appointees, their backgrounds, and the regulatory compliance context for these appointments. This fits the definition of a Board/Management Information filing.
2020-12-02 English
Notice of AGM
AGM Information Classification · 1% confidence The document is an official announcement from Beximco Pharmaceuticals regarding the scheduling and agenda of their upcoming Annual General Meeting (AGM). It outlines the business to be transacted, such as the adoption of financial statements, declaration of dividends, and election of directors. While it mentions the AGM, it is a notification/announcement of the meeting rather than the presentation materials used during the meeting itself. Therefore, it fits best as a regulatory filing (RNS) announcing the event.
2020-11-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.